CDT Equity (CDT) Other Working Capital Changes (2025 - 2026)
CDT Equity's (CDT) quarterly Other Working Capital Changes came in at $787000.0 in Q1 2026, up 208.63% YoY from $255000.0 in Q1 2025, and down 79.86% on a QoQ basis from $3.9 million in Q4 2025.
CDT Equity (CDT) Other Working Capital Changes (2025 - 2026) Analysis & Trends
CDT Equity (CDT) has 5 years of Other Working Capital Changes data on file, last reported at $787000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 21.43% year-over-year to -$34000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$131000.0 (changed N/A YoY) and the FY2025 annual result came in at -$125000.0, down 0.81% from the prior year.
- Other Working Capital Changes slipped to -$34000.0 in Q1 2026, from -$29000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of -$28000.0 in Q1 2025 to a low of -$38000.0 in Q3 2025.
- A 5-year average of $587211.6 and a median of $304000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes jumped 557.43% — and 2025, when it plunged 396.08%.
- Tracing CDT's Other Working Capital Changes over 2 years: stood at -$29000.0 in 2025, then retreated by 17.24% to -$34000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$34000.0 (Q1 2026), -$29000.0 (Q4 2025), and -$38000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35,000.00 |
| Jun 30, 2026 | -35,000.00 |
| Jun 30, 2026 | -35,000.00 |
| Mar 31, 2026 | -34,000.00 |
| Mar 31, 2026 | -34,000.00 |
| Mar 31, 2026 | -34,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | -38,000.00 |
| Sep 30, 2025 | -38,000.00 |
| Sep 30, 2025 | -38,000.00 |
| Jun 30, 2025 | -30,000.00 |
| Jun 30, 2025 | -30,000.00 |
| Jun 30, 2025 | -30,000.00 |
| Mar 31, 2025 | -28,000.00 |
| Mar 31, 2025 | -28,000.00 |
| Mar 31, 2025 | -28,000.00 |